Agree with your comments. I know lots of us would love to say as it is , but sure the most of what the vast majority of us can say, yes, we are shareholders and have a financial interest, think and even believe that the product is for the betterment of humanity and superior to any alternatives that exist (including the one the law firm with questionable ethics, but loving money trying to protect no to lose a couple of billions), the pub test says that if it is used under another fancy name in Japan for over 4 years and they are paying for it that either the Japanese do not know what they are doing or extremely lucky or......... the bloody things work, some other countries like our Kiwi and also Canadian bros approved it and we also would love it here in Oz and FDA approval would help us to convince our TGA. So if you care about your kids under 12 where nothing is approved presently hence no hope for them, don't worry about the Disallowed, but use your common sense. A mate for you from Down Under.
- Forums
- ASX - By Stock
- MSB
- Ann: FDA Advisory Committee Sets Review Date for Remestemcel-L
Ann: FDA Advisory Committee Sets Review Date for Remestemcel-L, page-269
-
-
- There are more pages in this discussion • 586 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add MSB (ASX) to my watchlist
(20min delay)
|
|||||
Last
94.0¢ |
Change
-0.020(2.08%) |
Mkt cap ! $1.073B |
Open | High | Low | Value | Volume |
95.5¢ | 97.0¢ | 93.5¢ | $1.424M | 1.507M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
8 | 29390 | 93.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
94.5¢ | 14089 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
6 | 24054 | 0.935 |
8 | 131583 | 0.930 |
4 | 65851 | 0.925 |
7 | 113334 | 0.920 |
9 | 97006 | 0.915 |
Price($) | Vol. | No. |
---|---|---|
0.945 | 1100 | 1 |
0.950 | 19026 | 2 |
0.955 | 27000 | 2 |
0.960 | 32869 | 2 |
0.965 | 35384 | 2 |
Last trade - 16.10pm 13/09/2024 (20 minute delay) ? |
Featured News
MSB (ASX) Chart |
The Watchlist
LPM
LITHIUM PLUS MINERALS LTD.
Simon Kidston, Non--Executive Director
Simon Kidston
Non--Executive Director
SPONSORED BY The Market Online